Daniel MARSHAK, Ph.D.
Chief Technology Officer
Dan provides overall direction in R&D for PHASE Scientific.
An industry veteran who was formerly Senior Vice President, Chief Scientific Officer and President of Greater China of Perkin Elmer (NYSE: PKI), Dan holds a number of board directorships, including InVivo Therapeutics (NASDAQ: NVIV) and Upside Biotechnologies. He is also Chief Scientific Officer of Ferghana Partners and Advisor at 5AM Ventures.
Dan earned his Ph.D. in Biochemistry from Rockefeller University, United States